Table 1.

Study MACE outcomes, 3 years after baseline MI, among women and men in the post-MI validation population

Study event	Female				P trend	Male				P trend
	n=181	n=174	n= 148	n= 73		n= 247	n= 671	n= 218	n= 154
	IMACE risk category					IMACE risk category
	Low	Mild	Mod	High		Low	Mild	Mod	High
	≤2 (%)	3–4 (%)	5–6 (%)	≥7 (%)		≤2 (%)	3–5 (%)	6–7 (%)	≥8 (%)
Primary outcome: MACE (composite of CV death, MI and stroke)
Composite endpoint	5.0	4.0	17.6	32.9	<0.001	4.5	4.8	12.4	19.5	<0.001
Secondary outcomes
MI	1.7	1.1	4.1	9.6	<0.001	2.8	2.5	6.0	5.8	0.012
Stroke	0.6	0.0	2.7	4.1	0.005	0.0	0.3	2.8	0.6	0.016
CV mortality	2.8	3.4	12.2	21.9	<0.001	1.6	2.4	6.0	14.3	<0.001
All-cause mortality	3.9	4.6	16.9	30.1	<0.001	2.8	3.3	8.3	17.5	<0.001

Sex-specific IMACE results are categorised as low, mild, moderate (mod) and high risk.

CV, cardiovascular; IMACE, Intermountain Major Adverse Cardiovascular Events; MACE, major adverse cardiovascular events; MI, myocardial infarction.